4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease - A pilot study

Zeitschrift fur Gastroenterologie

Volumn 39, Issue 4, 2001, Pages 279-285

  Luth S ^a   Teyssen, S ^a   Kolbel C B ^a   Singer, M V ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Eradication; Helicobacter pylori; Rabeprazole; Short term; Triple therapy

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; PROTON PUMP INHIBITOR; RABEPRAZOLE; UREA;

ADULT; AGED; ANUS PRURITUS; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; DRUG EFFICACY; DRUG TOLERABILITY; DUODENUM ULCER; ERADICATION THERAPY; FATIGUE; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PATIENT COMPLIANCE; PEPTIC ULCER; PILOT STUDY; RASH; STOMACH ACID SECRETION; STOMACH ULCER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; ANTI-ULCER AGENTS; BENZIMIDAZOLES; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PILOT PROJECTS;

EID: 0035030738     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12873     Document Type: Article

References (39)

1. Working party report to the World Congress of Gastroenterology, Sydney 1990
2. Helicobacter pylori in peptic ulcer disease
3. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients
4. Helicobacter pylori and the risk and management of associated diseases: Gastritis, ulcer disease, atrophic gastritis and gastric cancer
5. Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration
6. Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori
7. Efficacy and tolerability of a short-term, low-dose triple therapy for eradication of Helicobacter pylori
8. Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen
9. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate
10. Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer - A European multicentre study
11. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: A European multicentre study
12. Double-blind comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro-oesophageal reflux disease
13. Identification of the characteristics influencing the degree of antisecretory activity of PPIs
14. Evaluation of a new ultrashort triple therapy for Helicobacter pylori disease
15. Treating H. pylori shorter than one week - A real future perspective?
16. Inhibitory antimicrobial concentrations against Campylobacter pylori in gastric mucosa
17. Physicochemical properties of amphoteric beta-lactam antibiotics. I: Stability, solubility, and dissolution behavior of amino penicillins as a function of pH
18. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori
19. Inhibition of Helicobacter pylori urease by omeprazole
20. Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor
21. Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprazole
22. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection
23. Amoxicillin/metronidazole/omeprazole/clarithromycin: A new, short quadruple therapy for Helicobacter pylori eradication
24. Helicobacter pylori: Optimum diagnosis and test of cure
25. Eradication of Helicobacter pylori with pantoprazole and two antibiotics: A comparison of two short-term regimens
26. Only four days of quadruple therapy can effectively cure Helicobacter pylori infection
27. 4-day lansoprazole quadruple therapy: A highly effective cure for Helicobacter pylori infection
28. Four-day quadruple therapy as a routine treatment for Helicobacter pylori infection
29. Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infection
30. Long-term follow-up after cure of Helicobacter pylori infection with 4 days of quadruple therapy
31. Two-day "weekend" lansoprazole-quadruple therapy for Helicobacter pylori infection
32. Two-day versus one-week anti-Helicobacter therapy in controlled bleeding ulcers: A prospective randomized trial
33. Weekend therapy for the treatment of Helicobacter pylori infection
34. One-day therapy for treatment of Helicobacter pylori infection
35. A three-day octreotide-containing Helicobacter pylori eradication therapy for cure of peptic ulcers
36. Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: A pilot study
37. Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse
38. A three-day course of intravenous omeprazole plus antibiotics for H. pylori-positive bleeding duodenal ulcer
39. Short-term (6 days) eradication of Helicobacter pylori infection in the practice of a health insurance physician